Discover 649 paid clinical trials in Gainesville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 649
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
for
LVAD, Frailty, GI Bleed, Right Heart Failure, Infections,
Location: Gainesville FL, Chicago IL, Rochester MN,
Sponsor: International Consortium of Circulatory Assist Clinicians
Sex: All
Age: 18 - 70+
Code: NCT06039176
Recruiting
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
for
Gastrointestinal Cancer
Location: Gainesville FL, Miami Beach FL, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06596694
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
for
Pain
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 45 - 70+
Code: NCT05761860
Early_phase1, Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
for
Peripartum Cardiomyopathy, Postpartum
Location: Gainesville FL, Jacksonville FL, Tampa FL,
Sponsor: Dennis M. McNamara, MD, MS
Sex: Female
Age: 18+
Code: NCT05180773
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Gainesville FL, Jacksonville FL, Orlando FL, Tampa FL,
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
for
Bile Duct Cancer, Gall Bladder Cancer, Breast Cancer,
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT05000294
Phase1, Phase2, Recruiting
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)